Author:
Thalji Mousa,Vadlapatla Vamshi,Avgeropoulos Nicholas G,Ramakrishna Naren,Baidas Said
Publisher
Springer Science and Business Media LLC
Reference6 articles.
1. Belzutifan for renal cell carcinoma in von Hippel-Lindau disease;Jonasch E;N Engl J Med,2021
2. Supratentorial hemangioblastoma: clinical features, prognosis, and predictive value of location for von Hippel-Lindau disease;Mills SA;Neuro Oncol,2012
3. Targeting the HIF2-VEGF axis in renal cell carcinoma;Choueiri TK;Nat Med,2020
4. FDA approves belzutifan for cancers associated with von Hippel-Lindau disease. (2021). Accessed. October 5, 2022: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-belzutifan-cancers-associated-von-hippel-....
5. Stereotactic radiosurgery for central nervous system hemangioblastoma: systematic review and meta-analysis;Pan J;J Neurooncol,2018